Conditions: Metabolism and Nutrition Disorder Obesity Obstructive Sleep Apnoea
Keywords: OSA
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 359
Healthy volunteers: no

Brief summary:
This trial is conducted in North America. The aim of the trial is to investigate the effect of liraglutide in obese subjects with sleep apnoea.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: liraglutide intervention 2: placebo
Intervention descriptions: intervention 1: 3.0 mg liraglutide administered subcutaneously (s.c., under the skin) once daily for 32 weeks + diet and exercise intervention 2: Placebo administered subcutaneously (s.c., under the skin) once daily for 32 weeks + diet and exercise

Protocol document: